Introduction
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human Body Protection Compound found in gastric juice. With the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, BPC-157 has been the subject of extensive preclinical research over the past three decades, primarily focused on tissue repair, wound healing, angiogenesis, and gastrointestinal protection.
BPC-157 is one of the most widely studied research peptides in the preclinical literature, with a substantial body of animal model data across multiple organ systems. All BPC-157 products supplied by Alpha Peptides are intended strictly for in vitro and laboratory research use only and are not approved for human or veterinary administration.
Structure & Background
BPC-157 was first isolated and characterised by researchers at the University of Zagreb, Croatia, led by Professor Predrag Sikiric. It is a partial sequence of the naturally occurring Body Protection Compound found in human gastric juice, which has been associated with gastroprotective activity. The synthetic version (BPC-157) has been studied extensively in rodent models and has demonstrated remarkable stability in gastric acid, making it a useful research tool for studying gastrointestinal and systemic repair mechanisms.
Unlike many research peptides, BPC-157 appears to be active via multiple routes of administration in animal models, and has been studied both systemically and locally in various tissue repair contexts.
Proposed Mechanisms of Action
- Angiogenesis promotion: BPC-157 has been shown to upregulate VEGF (vascular endothelial growth factor) expression and promote the formation of new blood vessels. This pro-angiogenic activity is proposed as a key mechanism underlying its observed tissue repair effects, as new vasculature is essential for delivering nutrients and oxygen to healing tissue.
- Nitric oxide (NO) system modulation: Research has implicated the nitric oxide pathway in BPC-157’s effects, with studies reporting both NO-dependent and NO-independent mechanisms. NO plays a central role in vascular tone, inflammation regulation, and tissue repair.
- Growth factor upregulation: BPC-157 has been reported to increase expression of growth hormone receptor (GHR) in tendon fibroblasts, potentially sensitising tissue to endogenous GH signalling and accelerating repair processes.
- Tendon fibroblast proliferation: In vitro studies have demonstrated that BPC-157 promotes the proliferation and migration of tendon fibroblasts, the cells responsible for producing collagen and maintaining tendon structure.
- Cytoprotection: BPC-157 has demonstrated cytoprotective effects in gastrointestinal tissue, protecting against various forms of experimentally induced mucosal damage including NSAID-induced ulceration, alcohol-induced damage, and ischaemia-reperfusion injury.
- Dopaminergic and serotonergic modulation: Research has reported interactions with dopamine and serotonin systems, with BPC-157 showing effects in models of dopamine-related movement disorders and serotonin syndrome.
Key Research Findings
Tendon & Ligament Repair
Some of the most compelling preclinical data for BPC-157 comes from tendon and ligament repair models. Studies in rats have demonstrated accelerated healing of surgically transected Achilles tendons, with BPC-157-treated animals showing improved tensile strength, increased collagen organisation, and enhanced fibroblast activity compared to controls. Similar findings have been reported in medial collateral ligament and rotator cuff injury models.
Gastrointestinal Protection
BPC-157’s gastroprotective properties are among its most extensively documented effects. Animal studies have demonstrated protection against gastric ulceration induced by NSAIDs, ethanol, stress, and cysteamine. The peptide has also been studied in models of inflammatory bowel disease, with reports of reduced intestinal inflammation and improved mucosal integrity in treated animals.
Bone & Cartilage Research
Preclinical studies have investigated BPC-157 in bone fracture healing models, reporting accelerated callus formation and improved bone mineral density in treated animals. Research has also explored its effects in cartilage repair, with some studies reporting chondroprotective activity.
Neurological Research
A growing body of research has explored BPC-157’s effects in the central nervous system. Studies have reported neuroprotective effects in models of traumatic brain injury, spinal cord injury, and stroke, as well as effects on dopaminergic pathways relevant to movement disorders. The mechanisms proposed include anti-inflammatory activity, angiogenesis in neural tissue, and modulation of neurotransmitter systems.
Muscle Repair
Animal studies have investigated BPC-157 in models of muscle crush injury and surgical muscle transection, reporting accelerated functional recovery and improved histological outcomes in treated animals compared to controls.
Research Considerations
- The vast majority of BPC-157 research is preclinical (animal models). Human clinical trial data is very limited, and extrapolation from animal studies to human biology requires caution.
- Much of the foundational research originates from a single research group at the University of Zagreb. While the volume of published data is substantial, independent replication across diverse institutions would strengthen the evidence base.
- BPC-157 appears stable in gastric acid and has been studied via multiple administration routes in animal models, which has implications for experimental protocol design.
- Refer to the Certificate of Analysis (COA) supplied with each batch for purity and sequence confirmation data.
Reconstitution & Storage
BPC-157 should be reconstituted with bacteriostatic water to the required concentration. Store the reconstituted solution at 2–8°C and use within 28–30 days. For full guidance, refer to our Peptide Reconstitution Guide and Storage & Handling Guide.
Research Resources
Researchers can source BPC-157 10mg from Alpha Peptides, supplied with a full batch-specific COA. For related compounds studied in tissue repair and recovery research, explore our Recovery Research collection.
Disclaimer: All products sold by Alpha Peptides are intended strictly for in vitro research and laboratory use only. They are not approved for human or veterinary use, and this article does not constitute medical advice.
0 comments